+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Manufacturing Market, By Type, By Application, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • PDF Icon

    Report

  • 168 Pages
  • December 2022
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5714465
Stem cells can be used to develop new stem cell therapies for many untreatable diseases. Stem cell therapy, also known as regenerative medicine, uses stem cells to repair diseased, dysfunctional, or injured tissues. Stem cell therapies can be used to treat neurological, autoimmune, inflammatory, and orthopedic conditions as well as traumatic injuries. Today, doctors routinely use stem cells to treat aforementioned disorders. Stem cells hold great promise for new medical treatments.

Market Dynamics:

Rise in burden of chronic/neurological diseases, increase in focus on the development of stem cell therapies, growing public awareness about therapeutic potential of stem cell, growing awareness regarding the benefits of stem cell preservation, favorable government initiatives and support are major factors expected to aid in the growth of the global stem cell manufacturing market.

For instance, in September 2021, STEMCELL Technologies, in partnership with WiCell, launched human pluripotent stem cell characterization and banking services, making it easier for pluripotent stem cell researchers to achieve critical yet often overlooked steps. Moreover, in September 2021, LifeCell International received an investment of INR 225 crore from OrbiMed Asia Partners IV in return for a minority stake, which will enable the company to make a foray into new categories, such as fertility health and cell-based therapeutics.

Key Features of the Study:

  • This report provides in-depth analysis of the global stem cell manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stem cell manufacturing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include TAKARA BIO Inc., PHARMICELL Co., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global stem cell manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell manufacturing market.

Detailed Segmentation:

Global Stem Cell Manufacturing Market, By Type:

  • Product
  • Services

Global Stem Cell Manufacturing Market, By Application:

  • Stem Cell Therapy
  • Drug Discovery and Development
  • Stem Cell Banking

Global Stem Cell Manufacturing Market, By End-User:

  • Pharmaceutical and Biotechnology Companies & CRO
  • Cell Banks and Tissue Banks
  • Others

Global Stem Cell Manufacturing Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

Company Profiles:

  • TAKARA BIO Inc.
  • PHARMICELL Co., Ltd.
  • MEDIPOST Co.
  • Holostem Terapie Avanzate S.r.l.
  • Bio-Rad Laboratories
  • Anterogen Co., Ltd.
  • Osiris Therapeutics, Inc. (Smith & Nephew PLC)
  • Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.)
  • Nikon CeLL Innovation Co. Ltd. (Nikon Corporation)
  • Medinet Co. Ltd.
  • Cell and Gene Therapy Catapult
  • Bio Elpida
  • Miltenyi Biotec
  • Pluristem Therapeutics Inc.
  • Thermo Fischer Scientific
  • Merck Group
  • Corning Incorporated
  • Stem Cell Technologies
  • Lonza Group
  • Becton, Dickinson and Company
  • Sartorius
  • Cellular Dynamics (Fujifilm Holdings Corporation)

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End-User
  • Market Snapshot, By Geography
  • Publisher Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Increase in prevalence of chronic and neurological disorders
  • High cost associated with stem cell manufacturing
  • Increase in focus on the development of stem cell therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Merger and Acquisition Scenario
4. Global Stem Cell Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact
5. Global Stem Cell Manufacturing Market, By Type, 2022-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Product
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Stem Cell Manufacturing Market, By Application, 2022-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Stem Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Stem Cell Banking
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Stem Cell Manufacturing Market, By End-User, 2022-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Pharmaceutical and Biotechnology Companies & CRO
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Cell Banks and Tissue Banks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
8. Global Stem Cell Manufacturing Market, By Geography, 2022-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
9. Competitive Landscape
  • TAKARA BIO Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • PHARMICELL Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • MEDIPOST Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Holostem Terapie Avanzate S.r.l.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Anterogen Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Osiris Therapeutics, Inc. (Smith & Nephew PLC)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Nikon CeLL Innovation Co. Ltd. (Nikon Corporation)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Medinet Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cell and Gene Therapy Catapult
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bio Elpida
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Miltenyi Biotec
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Pluristem Therapeutics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Thermo Fischer Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Merck Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Corning Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Stem Cell Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Sartorius
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cellular Dynamics (Fujifilm Holdings Corporation)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Analyst Views
10. Section
  • Research Methodology
  • About the Author

Companies Mentioned

A selection of companies mentioned in this report includes:

  • TAKARA BIO Inc.
  • PHARMICELL Co., Ltd.
  • MEDIPOST Co.
  • Holostem Terapie Avanzate S.r.l.
  • Bio-Rad Laboratories
  • Anterogen Co., Ltd.
  • Osiris Therapeutics, Inc. (Smith & Nephew PLC)
  • Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.)
  • Nikon CeLL Innovation Co. Ltd. (Nikon Corporation)
  • Medinet Co. Ltd.
  • Cell and Gene Therapy Catapult
  • Bio Elpida
  • Miltenyi Biotec
  • Pluristem Therapeutics Inc.
  • Thermo Fischer Scientific
  • Merck Group
  • Corning Incorporated
  • Stem Cell Technologies
  • Lonza Group
  • Becton, Dickinson and Company
  • Sartorius
  • Cellular Dynamics (Fujifilm Holdings Corporation)